Physicians stand to earn big money when signing up patients for drug trials. And lately, some of those trials have been ...
Kenvue is facing an FDA petition to remove Benadryl’s active ingredient.
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's Enhertu in combination with Roche ...
During a colonoscopy, Tukey’s doctors spotted something that follow-up PET scans revealed to be a tumor. He and his doctors ...
Chemotherapy drugs that target cancer cells without damaging normal cells remain one of the key goals of precision medicine ...
“These findings by our University of Hawai‘i Cancer Center research team show that drug resistance is not necessarily the end ...
Harvey Risch, an epidemiologist respected for his cancer research, promoted the use of hydroxychloroquine during the pandemic ...
MedPage Today on MSN
Blockbuster Drug Lands First-Line Indication for HER2-Positive Breast Cancer
The FDA approved trastuzumab deruxtecan (T-DXd; Enhertu) in combination with pertuzumab (Perjeta) for the first-line ...
Teva Pharmaceuticals USA has issued a nationwide recall of hundreds of thousands of bottles of a commonly prescribed blood ...
The actress opened up about the importance of connection and community at the San Antonio Breast Cancer Symposium with ...
The monarch revealed the positive outlook in a recorded message broadcast on British television as part of a campaign to ...
News-Medical.Net on MSN
Study links low physical activity to higher lymphedema risk after cancer treatment
Lymphedema after head and neck cancer is considerably more common than previously assumed and can persist long after cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results